home   about   contact   links
MPT WWW
 
 

September 11, 2007

The Do-Gooders Strike Again

"We're from academia, and we're here to help you." No, I am not kidding. News reports yesterday inform us that "academic detailers" have begun visits to doctors' offices for the purpose of countering the information and goodies offered by pharmaceutical firms in efforts to expand the market for their medicines.

The "academics," by the way, actually are pharmacists and nurses, but never mind. The brainchild of this mindless scheme is Jerry Avorn, a professor at the Harvard Medical School and "drug-safety expert," who claims to know that the prescribing habits of physicians are influenced negatively by the blandishments of the drug companies, and that his army of academics or pharmacists and nurses---take your pick---will provide doctors with "nonindustry-based information about the benefits, risks, and costs of various treatments."

Precisely how does the good professor know that physicians are influenced in unproductive ways by those nefarious drug producers? Sorry: That's top secret. How do the blandishments of the drug company representatives get around FDA regulations about what can be claimed about a given drug? Ditto. What is the source of the "nonindustry-based" propaganda, oops, information to be flaunted by the academics? Since they are very unlikely to have conducted their own Phase I, II, and III testing protocols---trust me on this one, Jerry, your people cannot afford them---that too remains entirely obscure.

No, my friends, this effort to provide "objective" information to doctors is a rather obvious ideological campaign to delegitimize the provision of information by the private sector instead of government bureaucrats. Would Professor Avorn welcome into his classrooms individuals pointing out his own biases and errors? The question answers itself.

Posted by Benjamin Zycher at September 11, 2007 11:24 AM

Comments

Post a comment




Remember Me?


PRINT PAGE | EMAIL PAGE
 
IN THE SPOTLIGHT:
Free-Market Medicine
by Paul Howard, Ph.D.
August 20, 2008

FORUM

COMMENTARY

RESEARCH

Medical Progress

Intellectual Property
Rights & Innovation

Global Health & Bio-terrorism

Prescriptions for Policy

  
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org